PT3789402T - Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists - Google Patents

Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists

Info

Publication number
PT3789402T
PT3789402T PT201814480T PT20181448T PT3789402T PT 3789402 T PT3789402 T PT 3789402T PT 201814480 T PT201814480 T PT 201814480T PT 20181448 T PT20181448 T PT 20181448T PT 3789402 T PT3789402 T PT 3789402T
Authority
PT
Portugal
Prior art keywords
combination therapy
bispecific antigen
cell activating
activating bispecific
antigen binding
Prior art date
Application number
PT201814480T
Other languages
Portuguese (pt)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT3789402T publication Critical patent/PT3789402T/en

Links

PT201814480T 2015-05-11 2015-11-16 Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists PT3789402T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15167173 2015-05-11

Publications (1)

Publication Number Publication Date
PT3789402T true PT3789402T (en) 2022-09-06

Family

ID=53052762

Family Applications (2)

Application Number Title Priority Date Filing Date
PT157979543T PT3221355T (en) 2015-05-11 2015-11-16 Combination therapy of t cell activating bispecific antigen binding molecules cd3 abd folate receptor 1 (folr1) and pd-1 axis binding antagonists
PT201814480T PT3789402T (en) 2015-05-11 2015-11-16 Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT157979543T PT3221355T (en) 2015-05-11 2015-11-16 Combination therapy of t cell activating bispecific antigen binding molecules cd3 abd folate receptor 1 (folr1) and pd-1 axis binding antagonists

Country Status (1)

Country Link
PT (2) PT3221355T (en)

Also Published As

Publication number Publication date
PT3221355T (en) 2020-12-04

Similar Documents

Publication Publication Date Title
HUE059632T2 (en) Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists
HUS2300033I1 (en) Bispecific t cell activating antigen binding molecules
HK1254966A1 (en) Bispecific anti-cd19xcd3 t cell activating antigen binding molecules
HK1252857A1 (en) Anti-cd3 antibodies and methods of use
HK1252856A1 (en) Bispecific anti-ceaxcd3 t cell activating antigen binding molecules
HK1251474A1 (en) Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
IL286835A (en) Bispecific tetravalent antibodies and methods of makiing and using thereof
HK1254068A1 (en) Bispecific t cell activating antigen binding molecules
HK1252158A1 (en) Masked anti-cd3 antibodies and methods of use
IL251292A0 (en) T cell activating bispecific antigen binding molecules agiant folr1 and cd3
PT3789402T (en) Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists